cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Praxis Precision Medicines I
7 own
12 watching
Current Price
$78.26
$7.72
(10.94%)
1 Week Returns
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns
Created with Highstock 6.2.0

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
207.64M
52-Week High
52-Week High
86.93000
52-Week Low
52-Week Low
33.0099983
Average Volume
Average Volume
0.51M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization207.64M
icon52-Week High86.93000
icon52-Week Low33.0099983
iconAverage Volume0.51M
iconDividend Yield--
iconP/E Ratio--
What does the Praxis Precision Medicines I do?
Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company. It is focused on translating insights from genetic epilepsies into the development of therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. It is applying genetic insights to the discovery and development of therapies for neurological disorders through two platforms, using its understanding of shared biological targets and circuits in the brain. Its platform includes Cerebrum, a small molecule platform, which utilizes deep understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally available precision therapies, and Solidus, is an antisense oligonucleotide platform, is an efficient, targeted precision medicine discovery and development engine anchored on a proprietary, computational methodology. Its product candidates include ulixacaltamide, PRAX-562, PRAX-628 and elsunersen.
Read More
How much money does Praxis Precision Medicines I make?
Created with Highcharts 6.2.0Q2 2022Q1 2022Q3 2021Q2 2021Q1 20210 M
Total Revenue
News & Events about Praxis Precision Medicines I.
Globe Newswire
1 year ago
BOSTON, June 15, 2023 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, ...
Globe Newswire
1 year ago
Phase 3 program to include one parallel group study and one randomized withdrawal study mADL11 as primary endpoint Single 60 mg/day dose to be tested BOSTON, June 09, 2023 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating ...
Globe Newswire
1 year ago
BOSTON, April 06, 2023 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, ...
Globe Newswire
1 year ago
Based upon observed efficacy and safety profile, Praxis intends to engage with the FDA in an end of Phase 2 meeting and initiate a ulixacaltamide Phase 3 study for the treatment of essential tremor in 2H23 Ulixacaltamide demonstrated improvement in modified Activities of Daily Living (mADL) primary ...
Ticker Report
1 year ago
Praxis Precision Medicines, Inc. (NASDAQ:PRAX Get Rating) Equities research analysts at William Blair issued their Q1 2024 earnings estimates for Praxis Precision Medicines in a note issued to investors on Tuesday, February 7th. William Blair analyst M. Minter anticipates that the ...
Frequently Asked Questions
Frequently Asked Questions
What is Praxis Precision Medicines I share price today?
plus_minus_icon
Can Indians buy Praxis Precision Medicines I shares?
plus_minus_icon
How can I buy Praxis Precision Medicines I shares from India?
plus_minus_icon
Can Fractional shares of Praxis Precision Medicines I be purchased?
plus_minus_icon
What are the documents required to start investing in Praxis Precision Medicines I stocks?
plus_minus_icon
What is today’s traded volume of Praxis Precision Medicines I?
plus_minus_icon
What is today’s market capitalisation of Praxis Precision Medicines I?
plus_minus_icon
What is the 52-Week High and Low Range of Praxis Precision Medicines I?
plus_minus_icon
What percentage is Praxis Precision Medicines I down from its 52-Week High?
plus_minus_icon
What percentage is Praxis Precision Medicines I up from its 52-Week Low?
plus_minus_icon
Current Price
$78.26
$7.72
(10.94%)
1 Week Returns
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns
Created with Highstock 6.2.0

Get Started with as little as $1.00

Get Started with as little as $1.00